oracine has been researched along with 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in 1 studies
Studies (oracine) | Trials (oracine) | Recent Studies (post-2010) (oracine) | Studies (4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone) | Trials (4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone) | Recent Studies (post-2010) (4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone) |
---|---|---|---|---|---|
33 | 0 | 4 | 998 | 15 | 271 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Martin, HJ; Maser, E; Wsol, V | 1 |
1 other study(ies) available for oracine and 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone
Article | Year |
---|---|
11Beta-hydroxysteroid dehydrogenase type 1: purification from human liver and characterization as carbonyl reductase of xenobiotics.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Alcohol Oxidoreductases; Antineoplastic Agents; Carcinogens; Dimerization; Ethanolamines; Glucocorticoids; Humans; Inactivation, Metabolic; Isoquinolines; Lung; Microsomes, Liver; Nitrosamines; Xenobiotics | 2006 |